Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The succinate dehydrogenase [ubiquinone] flavoprotein subunit (SDHA) is a key component of the succinate dehydrogenase (SDH) complex (Complex II) located in the mitochondrial inner membrane. SDHA catalyzes the oxidation of succinate to fumarate in the citric acid cycle, transferring electrons to ubiquinone and linking the citric acid cycle with the electron transport chain. SDHA contains a covalently bound FAD cofactor essential for catalytic function. Mutations or dysfunction of SDHA is linked with metabolic disorders and cancer.
Inhibition of succinate dehydrogenase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (SDHA).